MHP（Medilead Healthcare Panel）
MHP（Medilead Healthcare Panel）
Top ＞ Services ＞ MHP
MHP is Medilead’s proprietary database and aims to be an organic database that provides data to support the health of all people.
As a service that embodies our company philosophy of leading happy lives through the future of healthcare, we provide meaningful information that cannot be obtained from existing real-world data or primary research alone.
MHP is currently utilized by many of our clients for research and creation of medical literature.
One of the largest healthcare databases in Japan
MHP is a collection of proprietary information that covers symptoms on both the disease and pre-disease levels and is one of Japan’s largest healthcare databases. The proprietary data consists of basic respondent information in addition to specific details such as QOL (EQ-5D), adherence status, health literacy, loss of productivity, and burden of care. This allows our clients to utilize research results from a multitude of perspectives to suit their needs. In addition, MHP has information on approximately 400,000 panel members at any given time, making it easy to conduct additional research.
The two phases of MHP
MHP consists of two phases based on the stage of research.
Among the up to 4.2 million survey panelists Medilead has access to, information from roughly 400,000 respondents is stored in the database.
A deep-dive research is done with respondents from Phase 1 who answered that they have been hospitalized/visited the hospital regularly in the past year. More in-depth information can be gathered from approximately 100,000 respondents in this phase.
Easily identify target respondents and deep dive with additional research
MHP can be used in two main ways. The first is by extracting and processing the data gained from phases 1 and 2 for immediate analysis.
The second is to conduct additional research by selecting specific respondents from the MHP proprietary panel. MHP has already conducted extensive interviews on more than 700 symptoms and diseases, including 306 designated intractable diseases, making it possible to approach patients more efficiently. The costs required to identify respondents and conduct additional surveys are often more reasonable compared to cases where everything must be built from scratch.
Because you can choose whether to use data from the MHP database, conduct additional research, or both, MHP can be fully utilized regardless of the scale of the research.
IRB approval means MHP can be used in clinical trials, epidemiological studies, and dissertation writing
As a cohort study, MHP conducts research with approval from the IRB (ethical review board). MHP meets all IRB standards, as is often required for epidemiological research and dissertation preparation, so you can leverage the information with confidence. MHP has been used on numerous occasions for dissertation writing and the creation of other medical literature.
If you are interested in our MHP-related services, please contact us using the inquiry form for more details.
Please contact us using either the dedicated inquiry form or the email address provided in our free-to-access reports. In the body of your inquiry, please include the purpose of your research (market research, analysis, dissertation, etc.) and the therapeutic area of interest.
We will respond by either email or phone to confirm the details of your inquiry.
In most cases, we will reach out to schedule a meeting in advance to provide a more detailed explanation of our services and further discuss the details of your inquiry, along with any other questions or requests you may have.
Following the meeting, we will provide an estimate for our services based on what was discussed. Costs and timelines for deliverables can vary depending on the scale of research, so please feel free to consult with us.
For corporate inquiries about the business of Medilead Inc., please press this button and contact us.Contact us
Tokyo Opera City Tower (24F) 3-20-2, Nishishinjuku Shinjuku-ku, Tokyo, 163-1424 Japan
TEL : +81-3-6859-2295 FAX : +81-3-6745-1168